Stereochemistry | ABSOLUTE |
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@]13[C@H](O)C[C@@]4([H])[C@]5([H])CC[C@H](C(C)=O)[C@@]5(C)CC[C@]4([H])[C@@]3(C)CC2
InChI
InChIKey=UGIARLNNAPRCPF-HUPPADNKSA-N
InChI=1S/C21H32O2/c1-12(22)15-4-5-16-14-10-18(23)21-11-13(21)6-9-20(21,3)17(14)7-8-19(15,16)2/h13-18,23H,4-11H2,1-3H3/t13-,14-,15+,16-,17-,18+,19+,20+,21+/m0/s1
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Cyclopregnol (neurosterone) is a synthetic pregnane steroid, developed in the 1950s by the British Drug Houses, Ltd, for the treatment of psychiatric disorders, such as anxiety, depression and obsessive behavior. In a clinical study, cyclopregnol was not superior to placebo and was inferior to chlorpromazine.